erteberel: Clinical Trials

3 trials of erteberel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 2, Completed 1

Follow erteberel: new trials by email Literature Review of erteberel trials Research Report on erteberel

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Estrogen Receptor Beta and Mood
Estradiol, ER Beta Agonist, Placebo - Perimenopause-Related Depression
Phase 2CompletedNational Institute of Mental Health (NIMH)742019-05-232025-09-16
The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia
LY500307 150mg, LY500307 75mg, Placebo - Schizophrenia
Phase 2TerminatedIndiana University952013-06-012019-07-02
A Study in Men With Benign Prostatic Hyperplasia
LY500307, Placebo - Benign Prostatic Hyperplasia
Phase 2TerminatedEli Lilly and Company4142010-04-012019-04-08

Conditions studied

Cognitive Dysfunction (1)  ·  Prostatic Hyperplasia (1)  ·  Schizophrenia (1)

Sponsors

Eli Lilly and Company (1)  ·  Indiana University (1)  ·  National Institute of Mental Health (NIMH) (1)

Countries

United States (3)  ·  Australia (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Russia (1)

Top investigators

Alan Breier, MD (1)  ·  Peter J Schmidt, M.D. (1)